CTHRC1: A Biomarker for Evaluation of Rheumatoid Arthritis Disease Activity
NCT04415502 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2020-06-04
Summary
The purpose of the study is to determine whether plasma levels of the collagen triple helix repeat containing (CTHRC1) protein can serve as a blood-based biomarker for diagnosis of rheumatoid arthritis (RA) ,and furthermore its correlation with disease activity
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-10-01
- Primary Completion
- 2021-04-01
- Completion
- 2021-05-01
More Related Trials
-
Novel Imaging Markers for Rheumatoid Arthritis
NCT01773681 ·Status: COMPLETED
-
Can Cytokines be Used as an Activation Marker
NCT04486027 ·Status: COMPLETED
-
CXCL10 As a Biomarker Of ILD in Patients WithRA
NCT04356066 ·Status: UNKNOWN ·Phase: NA
-
Triosephosphate Isomerase Level in Relation to Rheumatoid Aerthritis Activity and Structural Damage
NCT07105566 ·Status: NOT_YET_RECRUITING
-
Detection of Pathological Lymphocytes in Patients With Autoimmune Disease
NCT02813083 ·Status: COMPLETED
-
Metabolome Analysis in Patients With Rheumatoid Arthritis
NCT02960958 ·Status: UNKNOWN
-
Rheumatoid Arthritis Disease Activity and Sub Clinical Atherosclerosis
NCT03821090 ·Status: COMPLETED
-
Renal Resistive Index as a Predictor of Renal Involvement in Rheumatoid Arthritis
NCT06227442 ·Status: NOT_YET_RECRUITING
-
Early Rheumatoid Arthritis Lung Disease Study
NCT03192267 ·Status: RECRUITING
-
Synovial Tissue and Blood Signature of Rheumatoid Arthritis Patients With Disease Flare After Treatment Discontinuation for Sustained Remission.
NCT05767801 ·Status: UNKNOWN
-
Screening Protein Markers in Patients With Rheumatoid Arthritis and Hot-dampness and Blood Stasis Syndrome
NCT02408094 ·Status: UNKNOWN
-
Early RA Vascular Randomised Controlled Study
NCT01768923 ·Status: COMPLETED ·Phase: NA
-
The Relation Between Macrophage Migration Inhibitory Factor (MIF) and 25(OH) Vitamin D3 Serum Levels in Rheumatoid Arthritis
NCT04315818 ·Status: UNKNOWN
-
Cellular and Molecular Analysis of Synovial Tissue of Patients With Arthritis
NCT06737952 ·Status: NOT_YET_RECRUITING
-
Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiography
NCT01476956 ·Status: COMPLETED
-
Assessment of 14-3-3 η (Eta) Protein Antibodies in the Serum of Rheumatoid Arthritis Patients and Its Relation to Atherosclerosis.
NCT04937140 ·Status: UNKNOWN
-
Feasibility of a Cytokine Expression Profile in Immune Cells as an Orientation Tool in Therapeutic Decisions for Auto-inflammatory and Auto-immune Diseases
NCT03280797 ·Status: COMPLETED ·Phase: NA
-
Oral Metagenomic Biomarkers in Rheumatoid Arthritis
NCT02544334 ·Status: COMPLETED
-
Effects of Achieving SDAI Remission on Joint Space Outcomes Progression in Early Rheumatoid Arthritis: an HR-pQCT Study
NCT04324892 ·Status: UNKNOWN
-
Atherosclerosis in Rheumatoid Arthritis
NCT00990730 ·Status: COMPLETED
-
Identifying Novel Biomarkers in Early Rheumatology Patients
NCT03843658 ·Status: UNKNOWN
-
Alterations in CD8αβ and CD8αα T Cell Levels in Patients With Rheumatoid Arthritis
NCT05827562 ·Status: NOT_YET_RECRUITING
-
Accuracy of CBC Derived Markers Against CRP and ESR in Detecting Active Rheumatoid Arthritis in Upper Egypt
NCT07149194 ·Status: NOT_YET_RECRUITING
-
Adalimumab in Rheumatoid Arthritis. An Investigation of Wholebody MRI, Conventional MRI, CT and Circulating Biomarkers
NCT01029613 ·Status: COMPLETED
-
Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
NCT07301892 ·Status: RECRUITING